A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
CL Yauk, AH Harrill, H Ellinger-Ziegelbauer… - Regulatory Toxicology …, 2020 - Elsevier
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
CL Yauk, AH Harrill… - Regulatory …, 2020 - pubmed.ncbi.nlm.nih.gov
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
[PDF][PDF] A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
CL Yauk, AH Harrill… - Regulatory …, 2020 - researchgate.net
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies.
CL Yauk, AH Harrill, H Ellinger-Ziegelbauer… - 2020 - cabidigitallibrary.org
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies.
CL Yauk, AH Harrill, H Ellinger-Ziegelbauer… - Regulatory …, 2019 - europepmc.org
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
[HTML][HTML] A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies
CL Yauk, AH Harrill… - Regulatory toxicology …, 2020 - ncbi.nlm.nih.gov
Robust genomic approaches are now available to realize improvements in efficiencies and
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …
translational relevance of cancer risk assessments for drugs and chemicals. Mechanistic …